---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-004502"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T13:41:45.594949+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics effects 1-for-40 reverse stock split; symbol gets 'D' suffix for 20 days

## Summary
- Reverse stock split effective January 30, 2024 at a 1-for-40 ratio.
- Ticker symbol changes to 'SIGYD' for 20 business days per FINRA rules.
- Standard symbol 'SIGY' will resume after the 20-business-day period.
- No change in the company's CUSIP or par value was disclosed.

## SEC filing metadata
- accession: 0001493152-24-004502
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315224004502/0001493152-24-004502-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315224004502/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-004502
- JSON: https://secwatch.observer/filing/0001493152-24-004502.json
- Plain text: https://secwatch.observer/filing/0001493152-24-004502.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.